19th January 2022|News, Scientific Media LPLDL® from ProBiotix Health showcases statistically significant reductions in multiple coronary heart disease biomarkers in hypercholesterolemic adults
10th February 2021|News, Scientific Media OptiBiotix jointly funds new research project to understand how its microbiome modulation technologies could improve sleep, stress & anxiety
27th January 2021|News, Scientific Media New research indicates microbiome-modulator SlimBiome® may help to reduce weight, BMI and body fat
1st October 2020|News, Scientific Media New study reveals SlimBiome® benefits in managing obesity related health outcomes
13th February 2020|News, Scientific Media New OptiBiotix Health LPLDL® formulation demonstrates blood pressure reduction in new human study
7th December 2018|News, Scientific Media OptiBiotix receives CE mark approval for SlimBiome® weight management product
22nd October 2018|Investor Media, News, Scientific Media Optibiotix launches ProBiotix Health as a separate company, which could lead to an IPO
1st October 2018|News, Scientific Media Scientific success leads to strong portfolio of commercial deals for UK-based microbiome company, OptiBiotix Health
25th May 2018|News, Scientific Media Study shows novel probiotic reduces cholesterol more effectively than plant sterols/stanols
3rd May 2018|Scientific Media Abstract: Enzymatic synthesis of galacto-oligosaccharides targeting cholesterol reduction
